No Influence of Food on the Pharmacokinetics, Pharmacodynamics or Tolerability of the 24mg and 36mg Oral Tablet Formulations of Ximelagatran

Author： Ersdal Eva   Schützer Kajs-Marie   Lönnerstedt Carina   Ohlsson Lis   Wall Ulrika   Eriksson Ulf G.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.7, 2005-01, pp. : 425-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Age on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

By Johansson L.C.   Frison L.   Logren U.   Fager G.   Gustafsson D.   Eriksson U.G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 4, 2003-01 ,pp. : 381-392

Adis International

Access to resources Recommend Favorite

Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran

By Eriksson U.G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 743-753

Adis International

Access to resources Recommend Favorite

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

By Sarich T.C.  

Clinical Pharmacokinetics, Vol. 42, Iss. 5, 2003-01 ,pp. : 485-492

Adis International

Access to resources Recommend Favorite

No Influence of Mild-To-Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

By Wåhlander K.   Eriksson-Lepkowska M.   Frison L.   Fager G.   Eriksson U.G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite

No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

By Johansson L.C.   Andersson M.   Fager G.   Gustafsson D.   Eriksson U.G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 5, 2003-01 ,pp. : 475-484

Adis International

Access to resources Recommend Favorite